| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 10/06/2010 | CN101851289A Humanized antibody of H5 subtype avian influenza virus hemagglutinin and application thereof |
| 10/06/2010 | CN101851278A B cell activating factor antagonist as well as preparation method and application thereof |
| 10/06/2010 | CN101850126A Product for preventing and/or treating prostate cancer |
| 10/06/2010 | CN101850125A Application of targeted mouse APRIL small interfering RNA in medicaments for treating mouse colon cancer |
| 10/06/2010 | CN101850124A Albumin nanometer-ultrasonic microbubble carrier tissue type plasminogen activator gene target system and preparation method thereof |
| 10/06/2010 | CN101850116A Method for constructing virus live vector recombinant vaccine by utilizing transposon |
| 10/06/2010 | CN101850112A Novel recombinant vaccine used for preventing tuberculosis |
| 10/06/2010 | CN101850111A Novel vaccine used for preventing tuberculosis |
| 10/06/2010 | CN101850108A Methods and pharmaceutical compositions for healing wounds |
| 10/06/2010 | CN101391104B New use of oncolytic adenovirus recombinant of tumour cell single-expression immunoloregulation fator GM-CSF |
| 10/06/2010 | CN101220359B SiRNA sequence restraining bak gene expression |
| 10/06/2010 | CN101130774B Nucleotide molecule SR5B and its application in preparation of antidiabetic medicine |
| 10/06/2010 | CN101130773B Nucleotide molecule SR5B2 and its application in preparation of antidiabetic medicine |
| 10/06/2010 | CN100999734B Application in adenovirus expression carrier of humen immunoglobulin promoter |
| 10/05/2010 | US7807819 siRNA targeting survivin |
| 10/05/2010 | US7807818 Reverse-sense nucleotide sequences for use in treatment of ulcerative colitis, crohn's and/or inflammatory bowel disease |
| 10/05/2010 | US7807814 Compositions and methods for combined therapy of disease |
| 10/05/2010 | US7807813 Kit comprising amplification primers and an internal control sequence for use in detection of west nile viral genomes; assuring safety of blood supply |
| 10/05/2010 | US7807795 Antibodies to osteoprotegerin binding proteins |
| 10/05/2010 | US7807787 NELL-1 (Nel-like molecule-1) polypeptide for use in induction and treatment of bone formation and disorders |
| 10/05/2010 | US7807780 Multi-component biological transport systems |
| 10/05/2010 | US7807649 Antisense oligonucleotides; diabetes, rhabdomyosarcoma; screening for the modulators |
| 10/05/2010 | US7807648 G-rich polynucleotides for the treatment of Huntington's Disease |
| 10/05/2010 | US7807646 SHIP-deficiency to increase megakaryocyte progenitor production |
| 10/05/2010 | US7807618 Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone and other tissues |
| 10/05/2010 | US7807617 Peptide inhibitors of toxins derived from LL-37 |
| 10/05/2010 | US7807457 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 10/05/2010 | US7807444 Prokaryotic recombinant host cell for use as bioreactor; improved heteroloogous gene expression |
| 10/05/2010 | US7807430 Polypeptide of 250-419 contiguous amino acids of SEQ ID NO:1, where tyrosine 216 is phosphorylated and the polypeptide will crystallize; biological activity consisting of binding a GSK3 inhibitor and kinase activity; antidiabetic agents; Alzeimer's disease; antiinflammation agents; biological screening |
| 10/05/2010 | US7807412 Using platelete derived growth fator as tool in detection of modulators for prevention and treatment of cell proliferative disorders |
| 10/05/2010 | US7807396 Drug screening; Preventing amyloid plaque formation and/or growth by reacting amyloid peptides with peptidase via direction injection to the brain; gene expression; genetic engineering |
| 10/05/2010 | US7807384 Drug screening; identifying a candidate agent that inhibits the binding of low density lipoprotein binding protein-2 (LBP-2) to an LBP-2 binding molecule |
| 10/05/2010 | US7807373 Prostate specific gene, PCGEM1, and methods of using PCEGM1 to detect, treat, and prevent prostate cancer |
| 10/05/2010 | US7807355 drug screening; identifying a therapeutic for decreasing intraocular pressure raised due to frizzled related protein (FRP) overexpression; contacting a trabecular meshwork cell expressing a Wnt pathway component or a frizzled related protein gene product with a test compound |
| 10/05/2010 | US7807198 containing a polymer, a therapeutic agent, and a complexing agent, where the polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex; may be used to deliver a therapeutic agent in treatment of various disorders |
| 10/05/2010 | US7807176 Polypeptide promoting vascular endothelial cell growth |
| 10/05/2010 | US7807148 Organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1a |
| 10/05/2010 | US7807147 Tumor therapy with high affinity laminin receptor-targeted vectors |
| 10/05/2010 | US7807146 Recombinant Modified Vaccinia Ankara virus; encoding a polypeptide HER-2 antigen; administering tumoricidal dose of taxanes paclitaxel and docetaxel |
| 10/05/2010 | US7807145 Method of inducing neuronal production in the brain and spinal cord |
| 10/05/2010 | CA2428662C Small acid-soluble spore protein and uses thereof |
| 10/05/2010 | CA2259368C Efficient nucleus transfer with foetal fibroblasts |
| 09/30/2010 | WO2010111522A2 Mesenchymal stem cells producing inhibitory rna for disease modification |
| 09/30/2010 | WO2010110914A2 Mammalian genes involved in infection |
| 09/30/2010 | WO2010110408A1 Dna vaccine for alzheimer's disease |
| 09/30/2010 | WO2010110318A1 Therapeutic agent for arteriosclerotic diseases comprising nucleic acid |
| 09/30/2010 | WO2010110314A1 Therapeutic agent for pulmonary hypertension comprising nucleic acid |
| 09/30/2010 | WO2010109053A1 Methods and compositions for the treatment of cirrhosis and liver fibrosis |
| 09/30/2010 | WO2010108419A1 Use of pon gene cluster in preparing medicine for treating atherosclerosis |
| 09/30/2010 | WO2010059829A3 Compositions and methods for triggered release rna therapeutics |
| 09/30/2010 | WO2010036960A3 Methods for treating, diagnosing, and monitoring lupus |
| 09/30/2010 | US20100249376 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide |
| 09/30/2010 | US20100249218 Method to inhibit cell growth using oligonucleotides |
| 09/30/2010 | US20100249217 Modulators of pharmacological agents |
| 09/30/2010 | US20100249216 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 09/30/2010 | US20100249215 Oligomeric Compounds And Compositions For Use In Modulation Of Pri-miRNAs |
| 09/30/2010 | US20100249025 Peptide antagonists of vascular endothelial growth factor |
| 09/30/2010 | US20100248355 Methods for generating high titer helper-free preparations of released recombinant aav vectors |
| 09/30/2010 | US20100248240 Gene and protein relating to hepatocellular carcinoma and methods of use thereof |
| 09/30/2010 | US20100248205 Reovirus Clearance of Ras-Mediated Neoplastic Cells from Mixed Cellular Compositions |
| 09/30/2010 | US20100247662 Biologic Modulations with Nanoparticles |
| 09/30/2010 | US20100247572 Viruses encoding mutant membrane protein |
| 09/30/2010 | US20100247553 Goodpasture Antigen Binding Protein |
| 09/30/2010 | US20100247552 Pak modulators |
| 09/30/2010 | US20100247522 Linked purine pterin hppk inhibitors useful as antibacterial agents |
| 09/30/2010 | US20100247498 In vitro micro-organs, and uses related thereto |
| 09/30/2010 | US20100247486 Recombinant virus vector originating in HHV-6 or HHV-7, method of producing the same, method of transforming host cell using the same, host cell transformed thereby and gene therapy method using the same |
| 09/30/2010 | CA2756670A1 Mesenchymal stem cells producing inhibitory rna for disease modification |
| 09/30/2010 | CA2756596A1 Methods and compositions for the treatment of cirrhosis and liver fibrosis |
| 09/29/2010 | EP2233575A1 An anti-hcv vaccine and preparation methods and uses thereof |
| 09/29/2010 | EP2233573A1 A complex molecule interfering the expression of target genes and its preparing methods |
| 09/29/2010 | EP2233571A1 Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAS encoding the same |
| 09/29/2010 | EP2233148A1 Uses of pdcd5 polypeptide for tumor chemotherapy and organ protection |
| 09/29/2010 | EP2231197A2 Methods of generating expanded and re-differentiated adult islet beta cells for use in the treatment of diabetes |
| 09/29/2010 | EP1608411B1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure. |
| 09/29/2010 | CN1935254B Method for neuregulin treating cardio vascular disease, and composition |
| 09/29/2010 | CN1927403B Medicine for promoting pigling growth and improving pigling immunity and preparing method thereof |
| 09/29/2010 | CN101849014A Chimeric PUFA polyketide synthase systems and uses thereof |
| 09/29/2010 | CN101848923A Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 09/29/2010 | CN101845438A Sensitive diagnosis and relative treatment for cancers through 20 tumor specific related genes and products |
| 09/29/2010 | CN101845419A Recombinant adenovirus and application thereof |
| 09/29/2010 | CN101843905A Application of PON gene cluster in preparing medicaments for treating atherosclerosis |
| 09/29/2010 | CN101843641A Novel adenoviruses, nucleic acids coding therefor, and use thereof |
| 09/29/2010 | CN101224307B Acute progranulocyte leukemia DNA vaccine PML-RAR alpha 384-hIL-2 and preparing method and application thereof |
| 09/29/2010 | CN101085986B SARS coronavirus disturbance RNA and its uses |
| 09/28/2010 | US7803933 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1) |
| 09/28/2010 | US7803926 Immunology; immunogens; cloning; host cell biosynthesis |
| 09/28/2010 | US7803784 Modulation of T cell signaling threshold and T cell sensitivity to antigens |
| 09/28/2010 | US7803782 antisense or RNA interference, gene therapy; drug delivery; metabolic, muscular and vascular disorders, sports injuries, immune and infectious diseases, atrophy, anticarcinogenic agents |
| 09/28/2010 | US7803781 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 09/28/2010 | US7803780 gene therapy of transferring the CD9 gene for suppressing cardiac hypertrophy or cardiac tachycardia in a patient having a heart disease; viral or non-viral expression vector containing a sequence encoding a CD9 protein |
| 09/28/2010 | US7803766 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; long-acting action |
| 09/28/2010 | US7803752 Method of inducing neuronal production in the caudate nucleus and putamen |
| 09/28/2010 | US7803637 Compositions and methods for treatment of neoplastic disease |
| 09/28/2010 | US7803622 Adeno-associated virus vectors |
| 09/28/2010 | US7803621 Plasmid comprised of viral envelope protein for use as nucleic acid transfer tool in gene therapeutic; safe and high-efficiency vector for in-vitro and in-vivo gene transfer; drug delivery systems; for gene therapy and high throughput screening |
| 09/28/2010 | US7803617 Conditional gene vectors regulated in cis |
| 09/28/2010 | US7803613 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 09/28/2010 | US7803602 Method for overexpression of zwitterionic polysaccharides |
| 09/28/2010 | US7803577 Polynucleotide encoding a tropoelastin polypeptide; expression products and hybrid molecules of the derivatives and variants |